Literature DB >> 16597359

Can drug-bearing liposomes penetrate intact skin?

Gamal M M El Maghraby1, Adrian C Williams, Brian W Barry.   

Abstract

Using liposomes to deliver drugs to and through human skin is controversial, as their function varies with type and composition. Thus they may act as drug carriers controlling release of the medicinal agent. Alternatively, they may provide a localized depot in the skin so minimizing systemic effects or can be used for targeting delivery to skin appendages (hair follicles and sweat glands). Liposomes may also enhance transdermal drug delivery, increasing systemic drug concentrations. With such a multiplicity of functions, it is not surprising that mechanisms of liposomal delivery of therapeutic agents to and through the skin are unclear. Accordingly, this article provides an overview of the modes and mechanisms of action of different vesicles as drug delivery vectors in human skin. Our conclusion is that vesicles, depending on the composition and method of preparation, can vary with respect to size, lamellarity, charge, membrane fluidity or elasticity and drug entrapment. This variability allows for multiple functions ranging from local to transdermal effects. Application to dissimilar skins (animal or human) via diverse protocols may reveal different mechanisms of action with possible vesicle skin penetration reaching different depths, from surface assimilation to (rarely) the viable tissue and subsequent systemic absorption.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597359     DOI: 10.1211/jpp.58.4.0001

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  15 in total

1.  Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers.

Authors:  Ming Chen; Vivek Gupta; Aaron C Anselmo; John A Muraski; Samir Mitragotri
Journal:  J Control Release       Date:  2013-10-12       Impact factor: 9.776

Review 2.  Micro-scale devices for transdermal drug delivery.

Authors:  Anubhav Arora; Mark R Prausnitz; Samir Mitragotri
Journal:  Int J Pharm       Date:  2008-08-30       Impact factor: 5.875

3.  Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation.

Authors:  Fang Guo; Jinping Wang; Man Ma; Fengping Tan; Nan Li
Journal:  J Mater Sci Mater Med       Date:  2015-04-01       Impact factor: 3.896

4.  Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment.

Authors:  Mohammad A Obeid; Alaa A A Aljabali; Meriem Rezigue; Haneen Amawi; Hanin Alyamani; Shatha N Abdeljaber; Valerie A Ferro
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.

Authors:  Mikolaj Milewski; Nicole K Brogden; Audra L Stinchcomb
Journal:  Expert Opin Drug Deliv       Date:  2010-05       Impact factor: 6.648

Review 6.  A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine.

Authors:  Sonia Pandey; Purnima Tripathi; Arti Gupta; Jitendra Singh Yadav
Journal:  Drug Deliv Transl Res       Date:  2021-09-22       Impact factor: 4.617

7.  Undulating tubular liposomes through incorporation of a synthetic skin ceramide into phospholipid bilayers.

Authors:  Peng Xu; Grace Tan; Jia Zhou; Jibao He; Louise B Lawson; Gary L McPherson; Vijay T John
Journal:  Langmuir       Date:  2009-09-15       Impact factor: 3.882

8.  Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.

Authors:  Melissa A Tran; Raghavendra Gowda; Arati Sharma; Eun-Joo Park; James Adair; Mark Kester; Nadine Barrie Smith; Gavin P Robertson
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

9.  Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes.

Authors:  Sureewan Duangjit; Praneet Opanasopit; Theerasak Rojanarata; Tanasait Ngawhirunpat
Journal:  J Drug Deliv       Date:  2010-11-07

Review 10.  Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.

Authors:  Ahlam Zaid Alkilani; Maelíosa T C McCrudden; Ryan F Donnelly
Journal:  Pharmaceutics       Date:  2015-10-22       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.